HRTX - Heron Therapeutics, Inc. /de/ - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - HRTX (818033)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
18 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-10-04
HRTXTang Kevin CDirP - Purchase$17.50+285,7145,821,098+5%+$4,999,995
2019-10-03
HRTXQuart Barry DCEOP - Purchase$17.50+4,57194,652+5%+$79,993
2019-10-03
HRTXPoyhonen JohnEVP, Chief Commercial OfficerP - Purchase$17.50+5,14318,143+40%+$90,003
2019-05-22
HRTXPoyhonen JohnDirP - Purchase$17.55+3,00013,000+30%+$52,650
2019-05-15
HRTXChristian WaageDirP - Purchase$18.04+1,4001,400New+$25,262
2019-05-01
HRTXManhard KimberlyEVP, Drug DevelopmentS - Sale$18.86-1,1090-100%-$20,918
2018-11-02
HRTXManhard KimberlyEVP, Drug DevelopmentS - Sale$30.62-4940-100%-$15,125
D
2018-10-01
HRTXManhard KimberlyEVP, Drug DevelopmentS - Sale+OE$32.07-6,0000-100%-$192,433
2018-09-12
HRTXTang Kevin CDir, 10%S - Sale$35.75-2,695,0005,851,503-32%-$96,346,250
D
2018-07-02
HRTXManhard KimberlyEVP, Drug DevelopmentS - Sale+OE$37.53-6,0000-100%-$225,179
D
2018-07-02
HRTXHoffman RobertCFO, SVP, FinanceS - Sale+OE$38.17-30,0001,280-96%-$1,145,230
DM
2018-06-29
HRTXRosen RobertPresS - Sale+OE$38.98-225,0002,640-99%-$8,769,818
D
2018-06-21
HRTXQuart Barry DCEOS - Sale+OE$39.05-50,00069,600-42%-$1,952,500
2018-03-29
HRTXTang Kevin CDir, 10%P - Purchase$26.00+192,3088,546,503+2%+$5,000,008
D
2018-03-19
HRTXManhard KimberlyEVP, Drug DevelopmentS - Sale+OE$30.00-18,0000-100%-$540,000
D
2018-03-19
HRTXQuart Barry DCEOS - Sale+OE$29.75-100,00067,993-60%-$2,975,000
D
2018-03-14
HRTXQuart Barry DCEOS - Sale+OE$24.75-100,00067,993-60%-$2,475,000
D
2018-01-10
HRTXManhard KimberlyEVP, Drug DevelopmentS - Sale+OE$20.00-7,5840-100%-$151,680
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top